Author | Sally E. Carty, MD, FACS


Radioiodine-Resistant Differentiated Thyroid Cancer: Hope for the Future

August 14, 2009

BySteven P. Hodak, MD|Sally E. Carty, MD, FACS

In this helpful review, the authors catalog a number of the novel molecular agents now being examined for treatment of radioiodine-resistant, metastatic differentiated thyroid cancer. They also call for increased systematic study of outcomes through recruitment of patients into large-scale trials.